BIANCO LOUIS A

CIK 00012042601 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001204260

Recent Transactions

50 trades

Tax Payment
CTI BIOPHARMA CORP
Common Stock
2016-03-21$0.55/sh−46,556→ 622,933 total
Award
CTI BIOPHARMA CORP
Employee Stock Option (Right to Buy)
2015-12-23+1,600,000→ 1,600,000 total
Disposition to Issuer
CTI BIOPHARMA CORP
Common Stock
2015-12-23−236,858→ 669,489 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.15/sh−2,994→ 908,047 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.14/sh−806→ 911,041 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.13/sh−1,000→ 913,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.16/sh−1,100→ 906,447 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.13/sh−1,200→ 911,947 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.12/sh−1,000→ 914,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.10/sh−1,400→ 919,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.10/sh−800→ 920,547 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.16/sh−100→ 906,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.11/sh−200→ 915,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.11/sh−3,800→ 915,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.15/sh−500→ 907,547 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-11-19$1.14/sh−100→ 911,847 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.41/sh−300→ 926,847 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.42/sh−500→ 921,647 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.43/sh−200→ 921,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.40/sh−100→ 927,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.40/sh−800→ 927,247 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.43/sh−100→ 921,547 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.38/sh−1,100→ 930,247 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.39/sh−2,200→ 928,047 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-29$1.42/sh−4,700→ 922,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-10-22$1.58/sh−10,000→ 931,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.46/sh−3,457→ 946,994 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.47/sh−5,647→ 941,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.41/sh−44,200→ 986,948 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.38/sh−11,100→ 1,100,247 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.41/sh−15,650→ 1,031,148 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.40/sh−31,149→ 1,046,798 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.39/sh−22,200→ 1,077,947 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.43/sh−7,878→ 958,830 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.42/sh−20,140→ 966,708 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.44/sh−1,120→ 950,451 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.39/sh−100→ 1,100,147 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-29$1.43/sh−7,259→ 951,571 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-09-24$1.52/sh−10,000→ 1,111,347 total
Award
CTI BIOPHARMA CORP
Common Stock
2015-09-21+205,931→ 1,121,347 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-07-23$1.91/sh−10,000→ 915,416 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-06-25$2.18/sh−10,000→ 925,416 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-05-21$1.80/sh−10,000→ 935,416 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-04-23$1.93/sh−10,000→ 945,416 total
Tax Payment
CTI BIOPHARMA CORP
Common Stock
2015-03-21$1.94/sh−66,736→ 955,416 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-03-20$1.93/sh−15,900→ 1,057,952 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-03-20$1.94/sh−5,100→ 1,035,752 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-03-20$1.92/sh−10,000→ 1,075,152 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-03-20$1.95/sh−11,500→ 1,024,252 total
Sale
CTI BIOPHARMA CORP
Common Stock
2015-03-20$1.94/sh−17,100→ 1,040,852 total

Companies

CTI BIOPHARMA CORP
EVP, Finance & Administration

Recent Filings

Address

501 ELLIOT AVENUE WEST SUITE 400

SEATTLE, WA, 98119

View on SEC.gov